Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Prof. Che Ping Cheng, Wake Forest University School of Medicine, United States.

Dr. Che Ping Cheng, M.D., Ph.D., FAHA, is a distinguished cardiovascular physiologist and internal medicine specialist whose career has been dedicated to advancing the understanding of heart function and failure. From earning his medical degree in China to completing a Ph.D. in Physiology at Wayne State University, and later conducting pivotal postdoctoral research at Wake Forest School of Medicine, Dr. Cheng has consistently pursued excellence in science and education. His research on ventricular mechanics, volume loading, and heart failure has significantly influenced both experimental cardiology and clinical practice. Recognized as a Fellow of the American Heart Association, he is also a dedicated mentor, shaping the next generation of cardiovascular researchers through his academic leadership.

Profile

Scopus

 

šŸŽ“ Early Academic Pursuits

Dr. Che Ping Chengā€™s journey into medicine and science began in Nanjing, China, where he earned his M.D. degree from Nanjing Railway Medical University in 1977. His early academic path reflected a deep interest in understanding the intricacies of human health, particularly in cardiovascular physiology. Driven by a desire to expand his knowledge and research capabilities, Dr. Cheng pursued his Ph.D. in Physiology at Wayne State University School of Medicine in Detroit, Michigan, completing his degree in 1986. Under the mentorship of Dr. Robert S. Shepard, his doctoral work focused on exploring the mechanisms of cardiovascular response to volume loading in a canine model with tricuspid valvulectomy, setting a strong foundation for his lifelong focus on heart function and disease mechanisms.

šŸ©ŗ Professional Endeavors

Following his academic training, Dr. Cheng embarked on postdoctoral studies at the Bowman Gray School of Medicine (now part of Wake Forest School of Medicine), where he continued to cultivate his expertise in internal medicine and cardiovascular physiology. Between 1986 and 1988, he served as a Postdoctoral Fellow under the guidance of Dr. William C. Little. His research during this period focused on ventricular dynamics and the physiological factors affecting active ventricular filling, which would later inform his broader work on heart failure and cardiac function. Dr. Cheng has since remained at Wake Forest School of Medicine, where he is currently a distinguished member of the Section on Cardiovascular Medicine.

šŸ§Ŗ Contributions and Research Focus

Dr. Cheng’s career has been characterized by a deep commitment to advancing the understanding of cardiac hemodynamics, ventricular interaction, and heart failure mechanisms. His research has explored how ventricular function responds under altered physiological states, and how these responses inform disease progression and treatment strategies. His early animal model studies have provided critical insights into the interplay between structural and functional changes in the heart, especially in the context of diastolic dysfunction and volume overload conditions. Dr. Cheng has also made significant strides in translating these findings to clinical contexts, influencing how cardiologists approach diagnosis and therapy.

šŸ… Accolades and Recognition

Throughout his career, Dr. Cheng has received considerable recognition for his scholarly contributions. He is a Fellow of the American Heart Association (FAHA), an honor that reflects his standing in the field of cardiovascular research and his commitment to scientific excellence. His work has earned the respect of colleagues and institutions alike, leading to numerous invitations to contribute to collaborative projects, serve on peer-review panels, and mentor future generations of cardiovascular researchers.

šŸŒ Impact and Influence

Dr. Cheng’s work has had a lasting impact on both experimental and clinical cardiology. By elucidating the mechanistic basis of ventricular dysfunction, he has helped shift paradigms in heart failure management, particularly in the areas of ventricular interdependence and preload responsiveness. His research findings are frequently cited in textbooks and high-impact journals, and they continue to inform guidelines for cardiac care and interventions. Through his work at Wake Forest and beyond, Dr. Cheng has played a pivotal role in bridging laboratory discoveries with bedside applications.

šŸ‘Øā€šŸ« Legacy and Mentorship

As a respected mentor and educator, Dr. Cheng has dedicated a significant portion of his career to training medical students, residents, and postdoctoral fellows. His mentorship has influenced numerous emerging scholars in cardiovascular medicine, many of whom have gone on to successful academic and clinical careers. His guidance combines a rigorous scientific approach with a deep sense of responsibility to patient care and scientific integrity, shaping a legacy that extends well beyond his own research output.

šŸ”¬ Future Contributions and Vision

Looking ahead, Dr. Cheng remains committed to the advancement of cardiovascular research, with a continued focus on uncovering the cellular and mechanical determinants of heart disease. His vision includes fostering collaborative projects that integrate biomedical engineering, imaging, and computational modeling to further understand cardiac performance. With decades of experience and a forward-thinking approach, Dr. Chengā€™s future contributions are poised to leave a lasting mark on the field of translational cardiovascular medicine.

Publication

  1. Title: Increased CaMKII activation and contrast changes of cardiac Ī²1-and Ī²3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
    Authors: Sun, Xiaoqiang; Cao, Jing; Chen, Zhe; Ferrario, Carlos M.; Cheng, Cheping
    Year: 2023
    Journal: Heliyon

 

  1. Title: Calmodulin-dependent protein kinase II activation promotes kidney mesangial expansion in streptozotocin-induced diabetic mice
    Authors: Mikhailov, Alexei V.; Liu, Yixi; Cheng, Hengjie; Lin, Jen Jar; Cheng, Cheping
    Year: 2022
    Journal: Heliyon

 

  1. Title: Chronic GPR30 agonist therapy causes restoration of normal cardiac functional performance in a male mouse model of progressive heart failure: Insights into cellular mechanisms
    Authors: Zhang, Xiaowei; Li, Tiankai; Cheng, Hengjie; Groban, Leanne; Cheng, Cheping
    Year: 2021
    Journal: Life Sciences

 

  1. Title: Chronic Ca2+/calmodulin-dependent protein Kinase II inhibition rescues advanced heart failure
    Authors: Liu, Yixi; Shao, Qun; Cheng, Hengjie; Zhao, David Xiao Ming; Cheng, Cheping
    Year: 2021
    Journal: Journal of Pharmacology and Experimental Therapeutics

 

  1. Title: The Angiotensin-(1ā€“12)/Chymase axis as an alternate component of the tissue renin angiotensin system
    Authors: Ferrario, Carlos M.; Groban, Leanne; Wang, Hao; Sun, Xuming; Ahmad, Sarfaraz
    Year: 2021
    Journal: Molecular and Cellular Endocrinology

 

  1. Title: Reversal of angiotensin-(1ā€“12)-caused positive modulation on left ventricular contractile performance in heart failure: Assessment by pressure-volume analysis
    Authors: Li, Tiankai; Zhang, Zhi; Zhang, Xiaowei; Ferrario, Carlos M.; Cheng, Cheping
    Year: 2020
    Journal: International Journal of Cardiology

 

  1. Title: Female Heart Health: Is GPER the Missing Link?
    Authors: Groban, Leanne; Tran, Q. K.; Ferrario, Carlos M.; Wang, Hao; Lindsey, Sarah H.
    Year: (Not specified, but likely 2020 or 2021)
    Journal: (Not specified)

 

šŸ Conclusion

Dr. Cheng’s legacy is one of intellectual rigor, clinical relevance, and mentorship. His work has not only deepened the scientific understanding of cardiac physiology but has also shaped modern approaches to diagnosing and managing heart failure. With a career spanning continents and disciplines, Dr. Cheng continues to be a guiding force in cardiovascular medicine, and his future contributions are anticipated to further advance the frontiers of heart research and patient care.

 

Sukesh Sinha | Neuropharmacology | Lifetime achievement Award

Published on by Neuroscientists

Prof. Dr. Sukesh Sinha | Neuropharmacology | Lifetime achievement Award

Prof. Dr. Sukesh Sinha,Ā  National Institute of Nutrition-ICMR, India.

Dr. Sukesh Narayan Sinha, a seasoned toxicologist and research leader, has dedicated his career to advancing the fields of food safety, drug toxicology, pesticide toxicology, and pharmacology. Starting with a strong academic foundation in chemistry from Bihar University, he honed his expertise further through international training at the University of Helsinki and the CDC in the USA. Rising through the ranks of Indiaā€™s premier health research institutions under the ICMR, Dr. Sinhaā€™s career spans critical research roles that have directly impacted national health and safety policies. His global collaborations and leadership roles reflect a career built on scientific rigor, public service, and continuous learning.

Profile

Google Scholar

 

šŸŽ“ Early Academic Pursuits

Born on January 3rd, 1965, Dr. Sukesh Narayan Sinha’s academic journey began with a profound interest in the field of chemistry. He earned his B.Sc. Honours in Chemistry in 1989, followed by an M.Sc. in Chemistry in 1993, and later a Ph.D. in Chemistry in 1999ā€”all from Bihar University, Muzaffarpur. His pursuit of advanced scientific knowledge extended internationally, where he underwent specialized analytical skill development in toxicology at the University of Helsinki, Finland. These foundational years cemented his passion for chemical and toxicological research, shaping the path for a distinguished career in public health and environmental safety.

šŸ§Ŗ Professional Endeavors in Toxicology

Dr. Sinha’s career has been marked by continuous progression through India’s foremost medical and research institutions under the Indian Council of Medical Research (ICMR). Beginning as a Research Fellow at the National Institute of Malaria Research, he moved into industry as a Research Scientist at Alkame Laboratory. His return to the ICMR system in 2001 marked the beginning of a steady ascent through scientific ranksā€”from Scientist-B to his current post as Senior Grade Deputy Director (Scientist-F) at the ICMR-National Institute of Nutrition (NIN), Hyderabad. He also held key roles at the ICMR-National Institute of Occupational Health, contributing immensely to occupational and environmental health research.

šŸ§¬ Contributions and Research Focus

Specializing in Food Toxicology, Drug Research & Toxicology, Pesticide Toxicology, and Pharmacology, Dr. Sinha has focused on identifying and mitigating chemical risks in food and the environment. His work has had a direct impact on public health safety standards in India. Through advanced analytical techniques and interdisciplinary collaboration, he has played a central role in guiding policy and regulatory frameworks concerning food safety. His expertise has not only contributed to toxicological research but has also enhanced national capacities in monitoring hazardous substances affecting human health.

šŸŒ Global Collaborations and Scientific Exposure

Dr. Sinha’s vision and research have reached global platforms. Notably, he served as a Visiting Scientist at the University of Cincinnati, USA, where he collaborated with experts in Environmental Health. He also completed two intensive courses on health and safety under the Centers for Disease Control and Prevention (CDC) in Atlanta, USA. These international exposures have enriched his scientific perspective, enabling him to incorporate global best practices into Indiaā€™s health safety frameworks and toxicology research protocols.

šŸ… Accolades and Recognition

Throughout his career, Dr. Sinha has earned recognition for his commitment and excellence in scientific research. While specific awards are not listed, his steady promotion within the ICMR ranksā€”from Scientist-B to Scientist-Fā€”reflects institutional trust in his capabilities and leadership. His selection as a visiting scientist abroad and participation in elite training programs also underscore his status as a respected voice in toxicology and public health research.

šŸ“¢ Impact and Influence on Public Health

Through his extensive research and governmental role, Dr. Sinha has contributed to national strategies on food safety and toxic substance regulation. His input influences decisions affecting millions of citizens, especially in areas related to food contaminants, drug residues, and environmental pollutants. He continues to serve as a bridge between laboratory research and real-world applications that safeguard public health in India.

šŸ”¬ Legacy and Future Contributions

Dr. Sinhaā€™s legacy lies in his unwavering commitment to science and service. With decades of experience and an expanding portfolio of national and international collaborations, he is poised to continue influencing future research, shaping young scientific minds, and contributing to Indiaā€™s health security. His role at ICMR-NIN ensures that his insights and leadership will guide public health policies and toxicology advancements for years to come.

Publication

  • Quantification of organophosphate insecticides and herbicides in vegetable samples using the ā€œQuick Easy Cheap Effective Rugged and Safeā€ (QuEChERS) method and a high …
    SN Sinha, K Vasudev, MVV Rao ā€“ 2012

 

  • Distribution of pesticides in different commonly used vegetables from Hyderabad, India
    SN Sinha, MVV Rao, K Vasudev ā€“ 2012

 

  • Air pollution from solid fuels.
    SN Sinha, PK Nag ā€“ 2011

 

  • Environmental monitoring of benzene and toluene produced in indoor air due to combustion of solid biomass fuels
    SN Sinha, PK Kulkarni, SH Shah, NM Desai, GM Patel, MM Mansuri, … ā€“ 2006

 

  • Repeated episodes of endosulfan poisoning
    A Dewan, VK Bhatnagar, ML Mathur, T Chakma, R Kashyap, HG Sadhu, … ā€“ 2004

 

  • Effect of dissociation energy on ion formation and sensitivity of an analytical method for determination of chlorpyrifos in human blood, using gas chromatographyā€“mass …
    SN Sinha, R Pal, A Dewan, MM Mansuri, HN Saiyed ā€“ 2006

 

  • A novel method for pesticide analysis in refined sugar samples using a gas chromatographyā€“mass spectrometer (GCā€“MS/MS) and simple solvent extraction method
    SN Sinha, VK Bhatnagar, P Doctor, GS Toteja, NP Agnihotri, RL Kalra ā€“ 2011

 

  • A liquid chromatography mass spectrometry-based method to measure organophosphorous insecticide, herbicide and non-organophosphorous pesticide in grape and apple samples
    SN Sinha, MVV Rao, K Vasudev, M Odetokun ā€“ 2012

 

  • Quantification of organophosphate insecticides in drinking water in urban areas using lyophilization and high-performance liquid chromatographyā€“electrospray ionization-mass …
    SN Sinha, K Vasudev, MVV Rao, M Odetokun ā€“ 2011

 

  • Inhibition of protein glycation by procyanidinā€B2 enriched fraction of cinnamon: delay of diabetic cataract in rats
    P Muthenna, G Raghu, C Akileshwari, SN Sinha, P Suryanarayana, … ā€“ 2013

 

šŸ Conclusion

Dr. Sukesh Narayan Sinha stands as a respected figure in India’s scientific community, with an enduring impact on toxicology research and public health safety. His career reflects a seamless integration of deep scientific knowledge, practical application, and international collaboration. As he continues his service at ICMR-NIN, his contributions promise to leave a lasting legacy in strengthening food safety standards, environmental health, and public policy for future generations. Dr. Sinhaā€™s journey inspires commitment to research excellence and exemplifies the profound role of science in safeguarding society.

 

Nai-Bing Gu | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Nai-Bing Gu | Clinical Neuroscience | Best Researcher Award

Dr. Gu Naibing is a distinguished Chief Physician in the Department of Neurology at Xi’an Central Hospital, specializing in neuroimmunology. He has made significant contributions to the understanding of neurological diseases, particularly those related to autoimmune and inflammatory conditions of the nervous system. As a Master’s degree supervisor and an active member of several professional committees, Dr. Gu has established himself as a leader in the fields of neurology and neuroimmunology. His research, clinical expertise, and involvement in medical organizations have earned him recognition and influence in the medical community. His work continues to have a lasting impact on both the treatment of neurological diseases and the education of future healthcare professionals.

Profile

Scopus

 

šŸ‘Øā€āš•ļø Early Academic Pursuits

Dr. Gu Naibing embarked on his academic journey with a keen interest in neurology and medicine. After completing his medical degree, he pursued further studies in the specialized field of neurology, which led to the completion of his Master’s degree. Throughout his academic tenure, Dr. Gu consistently demonstrated a strong dedication to advancing his understanding of complex neurological conditions. His early academic endeavors set the foundation for a career focused on improving patient outcomes and advancing scientific knowledge in neuroimmunology.

šŸ’¼ Professional Endeavors

Dr. Gu Naibing has established himself as a prominent figure in the field of neurology. As a Chief Physician in the Department of Neurology at Xi’an Central Hospital, he plays a vital role in diagnosing and treating a wide range of neurological disorders. Additionally, he serves as a Master’s degree supervisor, contributing to the training and development of the next generation of medical professionals. His professional network includes multiple roles in prestigious committees, such as the Neuroimmunology Professional Committee of the Shaanxi Provincial International Medical Exchange Promotion Association and the Neurology Branch of the Xi’an Medical Association.

šŸ”¬ Contributions and Research Focus

Dr. Gu’s research primarily focuses on neuroimmunology, the intersection of the immune system and neurological diseases. His work has advanced understanding in this field, particularly with regard to the mechanisms underlying autoimmune disorders affecting the nervous system. By contributing to a deeper understanding of brain diseases, Dr. Gu’s research has had significant implications for the development of more effective treatments for patients suffering from conditions such as multiple sclerosis, encephalitis, and other neuroinflammatory disorders. His focus on integrating immunological and neurological disciplines has been pivotal in pushing the boundaries of clinical research.

šŸ† Accolades and Recognition

Throughout his career, Dr. Gu Naibing has earned several accolades and recognition for his outstanding contributions to the medical field. His involvement in various professional committees highlights his leadership and influence in the realm of neurology and neuroimmunology. As a standing committee member of the Neuroimmunology Group and the Neurology Professional Committee of the Shaanxi Health Care Association, Dr. Gu’s expertise and leadership are regularly sought after. His recognition extends beyond clinical practice, as he is frequently invited to contribute to national and international discussions on neurological care and research.

šŸŒ Impact and Influence

Dr. Gu Naibingā€™s influence extends beyond his clinical and research activities. Through his active involvement in professional organizations, he has had a profound impact on the development of neurology and neuroimmunology practices in China. His leadership in committees, particularly within the Shaanxi Medical Communication Association, has helped bridge gaps between medical professionals, facilitating the exchange of ideas and research findings. His dedication to fostering collaboration among medical communities has contributed to the enhancement of healthcare practices and the overall improvement of patient care.

šŸ§  Legacy and Future Contributions

As Dr. Gu Naibing continues his work, his legacy in the fields of neurology and neuroimmunology will undoubtedly inspire future generations of healthcare professionals. His commitment to advancing both clinical and research practices ensures that his contributions will have a lasting impact on the treatment of neurological diseases. Looking ahead, Dr. Gu is poised to continue making significant strides in neuroimmunology, with ongoing research and collaborations aimed at developing new therapeutic approaches. His future contributions promise to further shape the landscape of neurological healthcare, enhancing the lives of patients around the world.

šŸŒŸ Final Thoughts

Dr. Gu Naibing’s career has been defined by his passion for neurology, his commitment to advancing research, and his tireless efforts to improve patient outcomes. As a clinician, educator, and researcher, he has earned the respect and admiration of his peers, contributing significantly to the advancement of medical knowledge and patient care. With his continued dedication to the field, Dr. Guā€™s legacy is sure to endure, influencing both the scientific community and the generations of healthcare professionals who follow in his footsteps.

Publication

  • Title: Effect of BMSCs overexpressing intelectin-1 on angiogenesis in rats with cerebral infarction
    Authors: B. Zhu, K. Guo, L. Zha, L. Chang, N. Gu
    Year: 2025

 

  • Title: Salivary duct carcinoma presenting with unilateral multiple cranial nerve lesions and concurrent intracranial metastasis: A case report
    Authors: B. Zhu, Q. Zhang, K. Guo, Y. Yang, X. Jia
    Year: 2025

 

Conclusion

Dr. Gu Naibingā€™s career is a testament to his dedication to advancing the field of neurology and neuroimmunology. His groundbreaking research, leadership in medical committees, and commitment to education have shaped the future of neurological care in China. With his continued focus on improving patient care and expanding scientific knowledge, Dr. Gu is poised to make lasting contributions that will positively impact both the medical field and the lives of countless patients. His legacy will inspire future generations of researchers and clinicians in the realm of neurology.

 

Clotilde Guidetti | Neuropharmacology | Best Researcher Award

Published on by Neuroscientists

Dr. Clotilde Guidetti | Neuropharmacology | Best Researcher Award

Dr. Clotilde Guidetti, Harvard Medical School, Massachusetts General Hospital, United States.

Clotilde Guidetti is an accomplished early-career physician-scientist specializing in Child and Adolescent Neuropsychiatry. With a classical foundation and medical training from the University of Genoa, she excelled academically, earning multiple merit awards and graduating Summa Cum Laude. She completed her specialized residency at the Catholic University of Rome, further refining her clinical expertise. Clotildeā€™s research focus lies in neurodevelopmental disorders, behavioral interventions, and psychopharmacology in pediatric populations. She has already demonstrated promise as an independent researcher through competitive grant submissions and award-winning conference presentations. Based in Boston, she is actively shaping a career that bridges clinical care and scientific innovation.

Profile

Scopus

 

šŸŽ“ Early Academic Pursuits

Clotilde Guidetti began her academic journey with a deep-rooted passion for understanding the human mind and behavior. She earned her High School Diploma in Classical Studies from the prestigious State High School Andrea D’Oria, an early indication of her strong intellectual curiosity and dedication to learning. This foundation in classical education provided her with a broad humanistic perspective that continues to inform her clinical and research approach. She then pursued her Medical Degree at the University of Genoa, where she graduated Summa Cum Laude in 2020. Her academic record was consistently marked by distinction, earning multiple Academic Merit Awards for clinical excellence during her medical studies.

šŸ§  Professional Endeavors

Following her graduation, Dr. Guidetti further specialized in the field of Child and Adolescent Neuropsychiatry through a rigorous residency program at the Catholic University of Rome. Completed in November 2024, her residency was also distinguished with Summa Cum Laude honors, reflecting both her clinical acumen and compassionate engagement with young patients. Her professional training combined intensive clinical work with scholarly research, preparing her to address complex neurodevelopmental and psychiatric disorders in children and adolescents.

šŸ”¬ Contributions and Research Focus

Dr. Guidetti’s primary research interests lie at the intersection of neurodevelopment, behavioral disorders, and psychopharmacology in pediatric populations. Her clinical insights are deeply enriched by her scientific inquiries, particularly those focused on the early diagnosis and personalized treatment of neuropsychiatric conditions. She has already begun shaping her independent research path, as seen in her recent submission for the Brain & Behavior Research Foundation Young Investigator Grant in January 2025. Her project, currently under review, reflects her growing reputation as an emerging scholar in the domain of pediatric neuropsychiatry.

šŸ… Accolades and Recognition

Throughout her academic and clinical journey, Clotilde Guidetti has been the recipient of multiple honors that highlight her outstanding abilities. These include three Academic Merit Awards from the University of Genoa and a prestigious Erasmus Socrates Fellowship in 2017ā€“2018, which broadened her training in an international context. In 2022, she received the Attilio Sabato Award from the SocietĆ  Italiana di Neuropsicofarmacologia (SINPF) for the best poster presentationā€”an achievement that not only celebrated her communication skills but also her innovative scientific thinking in neuropsychopharmacology.

šŸŒ Impact and Influence

Though early in her career, Dr. Guidetti has already begun to leave a meaningful mark on the field of child and adolescent mental health. Her dual focus on clinical excellence and academic inquiry ensures that her work resonates both within medical communities and in the lives of the families she serves. With a practice grounded in empathy and scientific rigor, she exemplifies the new generation of clinician-scientists committed to transforming mental health care for the most vulnerable populations.

šŸ§¬ Legacy and Future Contributions

As she looks to the future, Clotilde Guidetti aims to expand her contributions to academic psychiatry through collaborative research, cross-disciplinary studies, and the mentorship of emerging professionals in the field. Her continued involvement in national and international research networks promises to amplify her influence, paving the way for innovative treatments and holistic models of care in pediatric neuropsychiatry. Her vision is firmly centered on early intervention, neurodevelopmental resilience, and the integration of clinical practice with cutting-edge neuroscience.

šŸ“š Academic Footprint

Dr. Guidetti currently resides and practices in Boston, Massachusetts, where she continues to build her clinical and research profile. Her dual baseā€”rooted in Italy and expanding into the United Statesā€”places her at the nexus of transatlantic collaboration. With each project and presentation, she further refines her expertise and extends her academic footprint, fostering a dynamic career defined by global engagement, intellectual integrity, and unwavering commitment to child and adolescent mental health.

Publication

  • Title: Antidepressants in the acute treatment of post-traumatic stress disorder in adults: a systematic review and meta-analysis

  • Authors: Guidetti, Clotilde; Feeney, Anna; Hock, Rebecca S.; Fava, Maurizio; Papakostas, George I.

  • Year: 2024

 

šŸ“ Conclusion

Dr. Guidetti embodies the ideal of a compassionate clinician and rigorous academic, poised to make significant contributions to the future of child and adolescent mental health. Her career so far reflects a seamless blend of scholarly excellence, clinical sensitivity, and a drive to push the boundaries of understanding in neuropsychiatry. As she continues to expand her research and collaborative efforts globally, her work promises to influence both scientific discourse and practical approaches in mental health careā€”building a legacy rooted in evidence, empathy, and innovation.

 

Soumya Pahari | Clinical Neuroscience | Young Researcher Award

Published on by Neuroscientists

Dr. Soumya Pahari | Clinical Neuroscience | Young Researcher Award

Dr. Soumya Pahari,Ā  Nepalese Army Institute of Health Sciences, Nepal.

Dr. Soumya Pahari, MBBS, is a globally engaged physician with a deep-rooted passion for neurosurgery, clinical research, and public health advocacy. From excelling in medical school on a full academic scholarship to completing hands-on neurosurgical training in both Nepal and the U.S., Dr. Pahari has built a career that blends clinical excellence with scholarly rigor. Their dedication to global neurosurgical research, reflected through projects with Vanderbilt University and Mission Brain Foundation, demonstrates a commitment to solving complex medical challenges through evidence-based innovation. Beyond the operating theater, their work as a mental health advocate and educator underscores a holistic approach to medicine that prioritizes human connection, education, and equity.

 

Profile

Google Scholar

 

šŸŽ“ Early Academic Pursuits

Dr. Soumya Pahariā€™s academic journey began with a strong foundation in science, nurtured during their high school years at St. Xavierā€™s College, Nepal, Ā Their passion for medicine soon led them to pursue an MBBS degree at the Nepalese Army Institute of Health Sciences (NAIHS), where they not only excelled academically but also earned the prestigious NAIHS Academic Scholarship in 2016. Throughout medical school, they developed a keen interest in neuroscience and surgical disciplines, which laid the groundwork for their future specialization in neurosurgery and global neurosurgical initiatives.

šŸ§  Professional Endeavors in Neurosurgery

Driven by an unrelenting commitment to clinical excellence, Dr. Pahariā€™s professional training includes a year-long position as House Officer in the Department of Neurosurgery at Shree Birendra Hospital, Nepal’s only neurosurgical unit under the Nepalese Army. Here, they performed critical procedures such as EVD insertion, burr hole evacuation, and tracheostomy, while actively assisting in advanced surgeries like aneurysm clipping and tumor resections. Later, as a Visiting Scholar in Neurosurgery at West Virginia University (WV, USA) under Dr. P. David Adelson, they broadened their exposure by shadowing surgeons, presenting clinical cases, and initiating a quality improvement project focused on vagal nerve stimulators for refractory epilepsy patients. These experiences have collectively enriched Dr. Pahariā€™s surgical acumen and global neurosurgical insight.

šŸ”¬ Contributions and Research Focus

Research forms a core pillar of Dr. Pahariā€™s career, with a focus on pediatric cerebrovascular disorders, endovascular interventions in extradural hematomas, and quality improvement in epilepsy care. As a Research Collaborator with Vanderbilt Global Neurosurgery Program, they are leading a systematic review to assess the global burden of pediatric cerebrovascular diseases, contributing meaningfully to evidence-based global neurosurgical strategies. Simultaneously, their work with the Mission Brain Foundation aims to analyze the emerging utility of endovascular techniques in traumatic brain injury management. Earlier, they also contributed as an administrator and content developer at the Abdulrauf University of Neurosurgeryā€™s Research Institute in California, helping curate educational content for aspiring neurosurgeon-scientists.

šŸŒ Advocacy, Mental Health & Global Impact

Dr. Pahariā€™s commitment to health extends beyond the operating room into the domain of mental health and psychosocial well-being. As a Founding Board Member of Antardhoni Nepal, theyā€™ve played a vital role in promoting mental health awareness and support services in underserved communities. Their leadership also reflects through media engagement as a Podcast Host for ‘Behind White Coats’, a platform where pressing global health issues and common illnesses are discussed with clarity and compassion. These endeavors underline their belief in a holistic approach to health, where mental, social, and physical well-being are equally prioritized.

šŸ† Accolades and Recognition

Throughout their academic and professional career, Dr. Pahari has garnered several accolades, notably being ECFMG Certified in August 2024 and scoring an impressive 253 on USMLE Step 2. Their achievements are further supported by certifications such as the Diploma in Neurotrauma Care from the Global Neuro Foundation, which granted them 43.5 AMA PRA Category 1 credits, enhancing their preparedness for managing acute neurotrauma in global contexts. These recognitions reflect their unwavering commitment to clinical excellence and continuous learning.

šŸ“¢ Influence Through Education and Media

An inspiring communicator and educator, Dr. Pahari has invested time in peer tutoring through Medlife Stories, where they guided junior students through complex medical concepts. Their innovative spirit also led them to head marketing strategies for The SET Exhibition during their early college yearsā€”an event that showcased student innovation in science and technology. Through educational content creation, public speaking, and mentoring, Dr. Pahari continues to shape the next generation of healthcare leaders while making medicine more accessible and engaging for all.

šŸš€ Legacy and Future Contributions

As Dr. Soumya Pahari looks ahead, their vision is clearly anchored in the intersection of clinical neurosurgery, global health equity, and academic research. With ongoing collaborations in global neurosurgical research and growing experience in both developed and developing healthcare systems, they are uniquely positioned to bridge disparities in neurosurgical care. Their future contributions are expected to amplify the voices of underrepresented populations in global health discourse, enhance neurosurgical systems through data-driven quality improvement, and inspire young physicians to approach medicine with both empathy and rigor. Their legacy, still unfolding, promises to be one of profound impact, innovation, and inclusion.

Publication

 

  • Title: Gallstone among patients presenting to the department of surgery in a tertiary care center: a descriptive cross-sectional study
    Authors: S Pahari, S Basukala, U Piya, Y Khand, B Thapa, O Thapa, S Thapa
    Year: 2023

 

  • Title: A rare case of retroperitoneal extension in Fournier’s gangrene: A case report and review of literature
    Authors: S Basukala, Y Khand, S Pahari, KB Shah, A Shah
    Year: 2022

 

  • Title: Large posterior mediastinal ganglioneuroma with intradural cervical spine extension: a rare case report and review of literature
    Authors: A Dahal, JJ Malla, D Neupane, N Lageju, LS Jaiswal, S Chaudhary, …
    Year: 2022

 

  • Title: Complicated pylephlebitis secondary to perforated appendicitis in a child-A rare case report
    Authors: S Pahari, M Shrestha, S Basukala, P Kafle, K Rai, Y Khand, O Thapa, …
    Year: 2022

 

  • Title: A life-threatening complication of biliary peritonitis following T-tube removal: A case report and review of literature
    Authors: Y Khand, S Basukala, U Piya, P Mainali, S Pahari, KB Shah
    Year: 2022

 

  • Title: Spontaneous splenic hematoma secondary to dengue infection: a rare case report
    Authors: S Pahari, S Basukala, P Kunwar, K Thapa, Y Khand, O Thapa
    Year: 2023

 

  • Title: An unusual case of perforated stump appendicitis: a case report
    Authors: S Basukala, BD Pathak, S Pahari, S Gurung, B Basukala, BB Rayamajhi, …
    Year: 2022

 

  • Title: Acute Pancreatitis among Patients Visiting the Department of Surgery in a Tertiary Care Centre: A Descriptive Cross-sectional Study
    Authors: S Basukala, BD Pathak, P Dawadi, S Bohara, A Tamang, S Pahari, …
    Year: 2023

 

  • Title: Patient Safety and organizational Safety Culture in Surgery: A Need of an Hour in the developing countries
    Authors: S Basukala, S Bohara, A Thapa, A Shah, S Pahari, Y Khand, O Thapa, …
    Year: 2022

 

  • Title: Acute recurrent pancreatitis in a child with pancreatic divisumā€“A case report
    Authors: O Thapa, S Basukala, M Shrestha, Y Khand, S Pahari, S Bohara, A Thapa, …
    Year: 2022

 

āœ… Conclusion

With a powerful blend of academic distinction, surgical skill, and compassionate advocacy, Dr. Soumya Pahari stands at the forefront of a new generation of physician-leaders. Their journey is a testament to the impact that global collaboration, research, and empathy can have on healthcare. As they continue to pursue excellence in neurosurgery and global health, their work promises not only to improve lives in the operating room but to inspire systemic change across borders. The future undoubtedly holds even greater contributions from this rising medical changemaker.

Camilla Bellone | Translational Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Camilla Bellone | Translational Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Camilla Bellone,Ā  University of Geneva, Switzerland.

Dr. Camilla Bellone is a renowned neuroscientist whose academic and research career has been marked by excellence, innovation, and impact. From her foundational training in Italy to her leadership role in Geneva, she has made pioneering contributions to understanding the neural underpinnings of social behavior. Her work bridges basic science and clinical relevance, and she has played a vital role in training, mentorship, and international collaboration within the neuroscience community.

Profile

Google Scholar

 

šŸŽ“ Early Academic Pursuits

Dr. Camilla Bellone began her academic journey with a Masterā€™s degree in Pharmacy from the University of Milano in 2000. With a strong foundation in pharmacology and medical chemistry, she pursued her Ph.D. in ā€œPharmacology, Toxicology, and Medical Chemotherapyā€ at the same institution, completing it in 2006. Her early education shaped a robust scientific mindset, preparing her for a career at the intersection of neuroscience and pharmacology. These formative years set the tone for her later work on the molecular mechanisms that govern complex behaviors in both healthy and diseased states.

šŸ§Ŗ Professional Endeavors

After her doctoral studies, Dr. Bellone enhanced her research acumen through a postdoctoral fellowship at the University of California, San Francisco (UCSF), gaining international exposure. She later returned to Switzerland, where she served as a scientist under the Ambizione Fellowship at the University of Geneva. Her academic path took a significant leap when she became an Assistant Professor at the University of Lausanne in 2014, followed by a transition to the University of Geneva in 2016. In 2020, she was promoted to Associate Professor in the Department of Basic Neuroscience, where she continues to lead cutting-edge investigations and mentor future neuroscientists.

šŸ§  Contributions and Research Focus

At the core of Dr. Belloneā€™s research lies a deep interest in the neurobiological basis of social behavior, with a particular focus on how these processes are disrupted in neuropsychiatric disorders. Her lab explores the synaptic and circuit-level mechanisms that underpin social cognition, often using advanced molecular and behavioral techniques. Her work has provided critical insights into how alterations in neural plasticity and connectivity contribute to diseases such as schizophrenia and autism spectrum disorders. With over 40 peer-reviewed publications in high-impact journals like Nature Neuroscience and Neuron, Dr. Bellone’s research continues to advance the field of behavioral neuroscience.

šŸ† Accolades and Recognition

Dr. Belloneā€™s scientific excellence has been recognized through several prestigious honors. In 2023, she received the EBBS Mid-Career Award and the Leenaards Scientific Prize for her collaborative project on cerebellar stimulation in schizophrenia. Earlier, she was elected to the distinguished FENS-KAVLI Network of Excellence in 2015, highlighting her position among Europe’s most promising neuroscientists. In 2014, she was honored with the Fondation du Prix Pfizer de la Recherche, marking an early milestone in her independent research career.

šŸŒ Impact and Influence

Beyond her lab, Dr. Bellone has made meaningful contributions to the academic and scientific community. She has delivered over 20 invited lectures at international conferences and institutions, sharing her discoveries with a global audience. As a dedicated mentor, she has guided eight masterā€™s students and seven PhD candidates, nurturing the next generation of neuroscientists. Her commitment extends to active service on academic committees, grant review panels, and editorial boards, reflecting her role as a respected leader in the field.

šŸ‘©ā€šŸ”¬ Balancing Science and Life

A champion of work-life integration, Dr. Bellone has managed to thrive professionally while embracing motherhood. She took two career breaks following the birth of her three children, exemplifying resilience and balance in a demanding academic landscape. Her story is an inspiration to young scientists, especially women, striving to build careers in STEM while honoring personal life choices.

šŸ”¬ Legacy and Future Contributions

Looking ahead, Dr. Belloneā€™s work holds promise for transforming our understanding of social dysfunction in mental illness. Her innovative approachesā€”blending circuit neuroscience, pharmacology, and behaviorā€”position her as a leading voice in the neurobiology of social behavior. With continued support from initiatives like the ERC Consolidator Grant, her research will likely pave the way for novel therapeutic interventions, leaving a lasting legacy in neuroscience and psychiatry.

Publication

  • Title: NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
    Author: P Paoletti, C Bellone, Q Zhou
    Year: 2013

 

  • Title: Cocaine triggered AMPA receptor redistribution is reversed in vivo by mGluR-dependent long-term depression
    Author: C Bellone, C LĆ¼scher
    Year: 2006

 

  • Title: Rapid bidirectional switching of synaptic NMDA receptors
    Author: C Bellone, RA Nicoll
    Year: 2007

 

  • Title: Cocaine inverts rules for synaptic plasticity of glutamate transmission in the ventral tegmental area
    Author: M Mameli, C Bellone, MTC Brown, C LĆ¼scher
    Year: 2011

 

  • Title: In vivo reprogramming of circuit connectivity in postmitotic neocortical neurons
    Author: A De la Rossa, C Bellone, B Golding, I Vitali, J Moss, N Toni, C LĆ¼scher, …
    Year: 2013

 

  • Title: Mechanisms of synaptic depression triggered by metabotropic glutamate receptors
    Author: C Bellone, C LĆ¼scher, M Mameli
    Year: 2008

 

  • Title: Effects of streptozotocinā€diabetes on the hippocampal NMDA receptor complex in rats
    Author: F Gardoni, A Kamal, C Bellone, GJ Biessels, GMJ Ramakers, F Cattabeni, …
    Year: 2002

 

  • Title: Neurons under T cell attack coordinate phagocyte-mediated synaptic stripping
    Author: G Di Liberto, S Pantelyushin, M Kreutzfeldt, N Page, S Musardo, R Coras, …
    Year: 2018

 

  • Title: mGluRs induce a longā€term depression in the ventral tegmental area that involves a switch of the subunit composition of AMPA receptors
    Author: C Bellone, C LĆ¼scher
    Year: 2005

 

  • Title: SHANK3 controls maturation of social reward circuits in the VTA
    Author: S Bariselli, S Tzanoulinou, C Glangetas, C PrĆ©vost-SoliĆ©, L Pucci, …
    Year: 2016

 

āœ… Conclusion

Dr. Belloneā€™s journey reflects a remarkable blend of scientific curiosity, academic leadership, and personal resilience. As she continues to explore the brain’s most intricate social circuits, her influence will undoubtedly expand across neuroscience, psychiatry, and therapeutic innovation. Her career serves as both a roadmap and an inspiration for emerging scientists navigating the evolving landscape of brain research.

 

Md Shimul Bhuia | Drug development of neurodegenerative disease | Young Scientist AwardĀ 

Published on by Neuroscientists

Mr. Md Shimul Bhuia | Drug development of neurodegenerative disease | Young Scientist AwardĀ 

Mr. Md Shimul Bhuia , BioLuster Research Center Limited,Ā  Bangladesh.

An accomplished pharmacist and researcher with expertise in pharmaceutical sciences, molecular docking, and drug development. Awarded the prestigious National Science and Technology Fellowship (NST) in 2023 for contributions to science. Extensive experience includes an internship at Beximco Pharmaceuticals, part-time pharmacy practice, and a full-time role as Deputy Director at BioLuster Research Center. Proficient in advanced software for computational drug design and well-versed in research methodologies. Fluent in Bangla and highly proficient in English, with strong technical and analytical skills.

 

profile

scholor

šŸŽ“ Education and Academic Achievements

Master of Pharmacy (M. Pharm.) Department of Pharmacy, Life Science Faculty. Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj-8100, Bangladesh Session: 2020ā€“2021 Course Duration: 1.5 years (3 Semesters)Passing Year: 2022 CGPA: 3.74 (out of 4.00). Bachelor of Pharmacy (B. Pharm.) Department of Pharmacy, Life Science Faculty .Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj-8100, BangladeshSession: 2016ā€“2017Ā  Course Duration: 4 years Honā€™s (8 Semesters) Passing Year: 2020 CGPA: 3.45 (out of 4.00) Ā Higher Secondary Certificate (H.S.C.) Ā Shahid Bul Bul Govt. College, Pabna Board: Rajshahi Group: Science Passing Year: 2016 GPA: 5.00 (out of 5.00)Ā Secondary School Certificate (S.S.C.) Kamal Pur T.M. High School, Ishwardi, PabnaĀ Board: Rajshahi Ā Group: ScienceĀ Passing Year: 2013Ā GPA: 5.00 (out of 5.00).

šŸŽÆ Research Interests

Neurology/Neurodegenerative Diseases , Immunology , Ā Cancer Therapy , Toxicology , Molecular Docking , Drug Design and Development via Computational Studies ,Pharmacological Investigation through Preclinical Test Systems , Inflammatory Diseases , Bioinformatics , Anti-cancer Agents

šŸ† Honours and Awards

National Science and Technology Fellowship (NST), 2023.Ā Awarded by the Ministry of Science and Technology, Government of Bangladesh

šŸ’¼ Work Experiences

InternshipBeximco Pharmaceutical Ltd., Squibb Road, Tongi, Bangladesh Duration: November 13, 2022, to November 23, 2022.Ā PharmacistĀ Worked as a pharmacist at Gafur Chikitsaloi (local pharmacy shop)Employee Status: Part-Researcher Deputy Director, BioLuster Research Center, Gopalganj 8100, Dhaka, Bangladesh Employee Status: Full-time (January 01 ā€“ Present)

šŸ“š Publications

 

Ā Conclusion

With a strong foundation in both clinical practice and academic leadership, Leila Sadatiā€™s career reflects a commitment to advancing healthcare education and patient safety standards. Her contributions in research, curriculum development, and operational management have shaped future medical professionals and enhanced patient care practices. As she continues to innovate and educate, her work remains instrumental in raising the standards of medical and surgical education in Iran and beyond.

 

 

Nawal Al-Subaie | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assist Prof Dr. Nawal Al-Subaie | Clinical Neuroscience | Best Researcher Award

Assist Prof Dr. Nawal Al-Subaie,Ā  Princess Noura University, Saudi Arabia

Nawal Al Subaie is a dedicated Clinical Pharmacist with extensive experience in clinical and academic roles at esteemed institutions, including Prince Sultan Military Medical City (PSMMC) and Princess Noura University (PNU). She holds a PhD in Clinical Pharmacy from DMU, UK, and a Masterā€™s in International Practice and Policy from UCL, London. With a career spanning leadership, clinical care, and education, she has made significant contributions to pharmacy practice, quality control, and chronic disease management. Her commitment to continuous learning is reflected in numerous specialized courses and symposiums, along with frequent contributions to global conferences.

 

profile

scholor

šŸŽ“ Educational Background

PhD in Clinical Pharmacy,DMU Leicester, United Kingdom.MSc in Clinical Pharmacy (International Practice and Policy)
,UCL School of Pharmacy, London, United Kingdom.Bachelorā€™s Degree in Hospital Pharmacy,King Saud University, Riyadh, Saudi Arabia.

šŸ’¼ Working Experience

Deputy in Charge of Pharmacy Division.Family and Community Medicine.Lead Pharmacist. Wazarat Health Centre (WHC).Clinical Pharmacist,Chronic Disease Clinic, WHC.Clinical Instructor / Trainer,Continuous education for pharmacy students at King Saud University, Princess Noura University, Northern Border University.Quality Control Representative Pharmacy, WHC.Part-time Lecturer,Clinical Ocular Pharmacology, King Saud University.JCI Accreditation Awardee,Primary Care Team.In-Charge of Clinical Pharmacist Ambulatory Care Clinics,Ā PSMMC, 2020ā€“2022.Assistant Professor,Princess Noura University (PNU), May 2022 ā€“ Present.

šŸ« Training Courses / Symposiums

2015 ā€“ 2019: PhD Student (Diabetes and Exercise)Pharmacy School, DMU, UK.2014: TOT CourseĀ Leicester, UK.2016: Phlebotomy CourseĀ Nottingham, UK.2016: First Aid CourseLeicester, UK.2022: ASHP Diabetes Management Certificate CourseĀ January ā€“ December 2022.

šŸŒ Conferences Attended & Contributions

2024: Attended the 4th Saudi Society of Clinical Pharmacist Annual International Conference (September).2024: Presented Poster at Dubai International Pharmaceuticals and Technologies Conference.2023: Oral Presentation at Neurology Conference, Dubai (March).2023: Judge, Pharmacy Research Day, PNU Research Center (May).2022: Attended First Saudi Society of Clinical Pharmacist Annual International Conference (September)(and many more from 2000 to 2024)

šŸ¤² Voluntary Work

University orientation for new students, DMU. Diabetes Awareness Day, in collaboration with Diabetes UK. Trained students at DMU on ELISA and Randox machine for blood sample analysis. Assisted pharmacy students with projects and dissertations, DMU

šŸ… Professional Memberships

Saudi Commission for Health Specialties (ID: 09-R-P-0295492)

šŸ“š Publications

  1. Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review
    Authors: N. Alsubaie, H.M. Al-Kuraishy, A.I. Al-Gareeb, B. Alharbi, M. De Waard, …
    Year: 2022

 

  1. Discussing Pathologic Mechanisms of Diabetic Retinopathy & Therapeutic Potentials of Curcumin and Ī²-glucogallin in the Management of Diabetic Retinopathy
    Authors: M. Rohilla, S. Bansal, A. Garg, S. Dhiman, S. Dhankhar, M. Saini, S. Chauhan, …
    Year: 2023

 

  1. The Potential Therapeutic Effect of Metformin in Type 2 Diabetic Patients with Severe COVID-19
    Authors: H.M. Al-Kuraishy, A.I. Al-Gareeb, A.A. El Kholy, E. El-Khateeb, A. Alexiou, …
    Year: 2023

 

  1. The Effects of a Combined Exercise Programme Aerobic and Resistance on Blood Glucose, Incretin, Metabolic and Inflammatory Mediators that Could Control the Diabetes and Improve ā€¦
    Author: N. Alsubaie
    Year: 2019

 

  1. Corrigendum to “Discussing Pathologic Mechanisms of Diabetic Retinopathy & Therapeutic Potentials of Curcumin and Ī²-glucogallin in the Management of Diabetic Retinopathy”
    Authors: M. Rohilla, S. Bansal, A. Garg, S. Dhiman, S. Dhankhar, M. Saini, S. Chauhan, …
    Year: 2024

 

  1. Impact of Clinical Pharmacist Diabetes Clinic on the Improvement of Health Outcomes in Type 2 Diabetes Subjects
    Authors: N. AlSubaie, M. Alsallal, S. AlTwaijri, A. AlOtaibi, B. AlHarbi, M. AlEissa, …
    Year: 2022

 

  1. The Effects of a Combined Aerobic and Resistance Exercise Programme on Insulin Resistance Among Prediabetes Subjects
    Authors: B. Alharbi, N. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Effects of a Combined Exercise Programme (Aerobic and Resistance) on Blood Glucose and Incretin Hormone That Could Control the Diabetes in Type 2 Diabetes
    Authors: N. Alsubaie, B. Alharbi, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Effects of a Combined Exercise Programme (Aerobic and Resistance) on Blood Glucose, and Incretin Hormone That Could Control the Diabetes in Type 2 Diabetes
    Authors: B.M. Alharbi, N.S. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

  1. The Impact of Moderate Combination Exercise on HbA1c, IL-6, and TNF in Type 2 Diabetic and Non-diabetic Subjects: An Interventional Non-randomized Clinical Trial
    Authors: B. Alharbi, N. Alsubaie, T.S. Sahota, M.J. Taylor
    Year: 2019

 

Ā Conclusion

Dr. Al Subaieā€™s career showcases a deep commitment to enhancing patient care, advancing pharmaceutical education, and contributing to international health discussions. Her background in both hands-on clinical care and academic research equips her with a well-rounded perspective, making her a valuable asset in clinical and educational settings alike. She continues to make strides in diabetes management, chronic disease care, and pharmacy education, with her work recognized through multiple presentations, awards, and professional memberships.